Skip to main content

Closed

ORIC: ORIC Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-35.5%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio16.33×

ORIC Pharmaceuticals, Inc.

ORICNASDAQ Global Select·USD·Closed

ORIC Pharmaceuticals, Inc.

ORICNASDAQ·USD·Closed

$11.07

−4.90%

$11.07

−$0.57 (4.90%)

52W Range

50thpctl

Volume

0.73×avg

Mkt Cap

1.15BUSD

P/E

-7.7TTM

Div Yield

–ann

52W Range

50thpctl

Volume

0.73×avg

Market Cap

1.15BUSD

P/E Ratio

-7.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings